These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 33748988)

  • 1. Drupin, a thrombin-like protease prompts platelet activation and aggregation through protease-activated receptors.
    Manjuprasanna VN; Urs AP; Rudresha GV; Milan Gowda MD; Jayachandra K; Hiremath V; Rajaiah R; Vishwanath BS
    J Cell Biochem; 2021 Aug; 122(8):870-881. PubMed ID: 33748988
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Drupin, a cysteine protease from Ficus drupacea latex accelerates excision wound healing in mice.
    Manjuprasanna VN; Rudresha GV; Urs AP; Milan Gowda MD; Rajaiah R; Vishwanath BS
    Int J Biol Macromol; 2020 Dec; 165(Pt A):691-700. PubMed ID: 33010277
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Thrombin-like serine protease, antiquorin from Euphorbia antiquorum latex induces platelet aggregation via PAR1-Akt/p38 signaling axis.
    Urs AP; Manjuprasanna VN; Rudresha GV; Hiremath V; Sharanappa P; Rajaiah R; Vishwanath BS
    Biochim Biophys Acta Mol Cell Res; 2021 Mar; 1868(3):118925. PubMed ID: 33333088
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The ATP-gated P2X1 receptor plays a pivotal role in activation of aspirin-treated platelets by thrombin and epinephrine.
    Grenegård M; Vretenbrant-Oberg K; Nylander M; Désilets S; Lindström EG; Larsson A; Ramström I; Ramström S; Lindahl TL
    J Biol Chem; 2008 Jul; 283(27):18493-504. PubMed ID: 18480058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet protease-activated receptor (PAR)4, but not PAR1, associated with neutral sphingomyelinase responsible for thrombin-stimulated ceramide-NF-κB signaling in human platelets.
    Chen WF; Lee JJ; Chang CC; Lin KH; Wang SH; Sheu JR
    Haematologica; 2013 May; 98(5):793-801. PubMed ID: 23065519
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Protease-activated receptors 1 and 4 do not stimulate G(i) signaling pathways in the absence of secreted ADP and cause human platelet aggregation independently of G(i) signaling.
    Kim S; Foster C; Lecchi A; Quinton TM; Prosser DM; Jin J; Cattaneo M; Kunapuli SP
    Blood; 2002 May; 99(10):3629-36. PubMed ID: 11986217
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Biphasic kinetics of activation and signaling for PAR1 and PAR4 thrombin receptors in platelets.
    Covic L; Gresser AL; Kuliopulos A
    Biochemistry; 2000 May; 39(18):5458-67. PubMed ID: 10820018
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipid Receptor GPR31 (G-Protein-Coupled Receptor 31) Regulates Platelet Reactivity and Thrombosis Without Affecting Hemostasis.
    Van Doren L; Nguyen N; Garzia C; Fletcher EK; Stevenson R; Jaramillo D; Kuliopulos A; Covic L
    Arterioscler Thromb Vasc Biol; 2021 Jan; 41(1):e33-e45. PubMed ID: 33267659
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Protease-activated receptor-4 (PAR4) variant influences on platelet reactivity induced by PAR4-activating peptide through altered Ca
    Morikawa Y; Kato H; Kashiwagi H; Nishiura N; Akuta K; Honda S; Kanakura Y; Tomiyama Y
    Thromb Res; 2018 Feb; 162():44-52. PubMed ID: 29289806
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Protease-activated receptor 4 activity promotes platelet granule release and platelet-leukocyte interactions.
    Rigg RA; Healy LD; Chu TT; Ngo ATP; Mitrugno A; Zilberman-Rudenko J; Aslan JE; Hinds MT; Vecchiarelli LD; Morgan TK; Gruber A; Temple KJ; Lindsley CW; Duvernay MT; Hamm HE; McCarty OJT
    Platelets; 2019; 30(1):126-135. PubMed ID: 30560697
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The roles and mechanisms of PAR4 and P2Y12/phosphatidylinositol 3-kinase pathway in maintaining thrombin-induced platelet aggregation.
    Wu CC; Wu SY; Liao CY; Teng CM; Wu YC; Kuo SC
    Br J Pharmacol; 2010 Oct; 161(3):643-58. PubMed ID: 20880402
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thrombin induces platelet activation in the absence of functional protease activated receptors 1 and 4 and glycoprotein Ib-IX-V.
    Lova P; Canobbio I; Guidetti GF; Balduini C; Torti M
    Cell Signal; 2010 Nov; 22(11):1681-7. PubMed ID: 20600849
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Role of adenosine diphosphate in the course of thrombin signal transmission].
    Han Y; Lu XX; Wang ZY; Dai L; Shen WH; Wu DP; Ruan CG
    Zhonghua Yi Xue Za Zhi; 2006 Dec; 86(46):3299-301. PubMed ID: 17313817
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease-activated receptors 1 and 4 mediate activation of human platelets by thrombin.
    Kahn ML; Nakanishi-Matsui M; Shapiro MJ; Ishihara H; Coughlin SR
    J Clin Invest; 1999 Mar; 103(6):879-87. PubMed ID: 10079109
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Newborn platelets: lower levels of protease-activated receptors cause hypoaggregability to thrombin.
    Schlagenhauf A; Schweintzger S; Birner-Gruenberger R; Leschnik B; Muntean W
    Platelets; 2010; 21(8):641-7. PubMed ID: 20807173
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protease-Activated Receptor 4 Variant p.Tyr157Cys Reduces Platelet Functional Responses and Alters Receptor Trafficking.
    Norman JE; Cunningham MR; Jones ML; Walker ME; Westbury SK; Sessions RB; Mundell SJ; Mumford AD
    Arterioscler Thromb Vasc Biol; 2016 May; 36(5):952-60. PubMed ID: 26966273
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antithrombotic effects of PAR1 and PAR4 antagonists evaluated under flow and static conditions.
    Hosokawa K; Ohnishi T; Miura N; Sameshima H; Koide T; Tanaka KA; Maruyama I
    Thromb Res; 2014 Jan; 133(1):66-72. PubMed ID: 24268424
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Comparison of the effects of PAR1 antagonists, PAR4 antagonists, and their combinations on thrombin-induced human platelet activation.
    Wu CC; Teng CM
    Eur J Pharmacol; 2006 Sep; 546(1-3):142-7. PubMed ID: 16890935
    [TBL] [Abstract][Full Text] [Related]  

  • 19. PAR4-Mediated PI3K/Akt and RhoA/ROCK Signaling Pathways Are Essential for Thrombin-Induced Morphological Changes in MEG-01 Cells.
    Heo Y; Jeon H; Namkung W
    Int J Mol Sci; 2022 Jan; 23(2):. PubMed ID: 35054966
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The antithrombotic effect of aprotinin: actions mediated via the proteaseactivated receptor 1.
    Poullis M; Manning R; Laffan M; Haskard DO; Taylor KM; Landis RC
    J Thorac Cardiovasc Surg; 2000 Aug; 120(2):370-8. PubMed ID: 10917956
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.